NCT00465296View on ClinicalTrials.gov

Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS

PHASE3TerminatedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Metabolic Syndrome
Interventions
DRUG

rosiglitazone

Trial Locations (1)

20010

Washington Hospital Center, Washington D.C.

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Medstar Health Research Institute

OTHER